Benicar Lawsuit Settlement Reached

Analyze My Case
  • Last Updated: August 11th, 2023
Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

Benicar Lawsuit Settlement Reached

August 1, 2017 – Daiichi Sankyo, the manufacturer of top-selling Benicar, Benicar HCT, Azor and Tribenzor has agreed to a $300 million settlement for individuals who experienced GI injuries as a result of taking one of its blood pressure drugs prior to 5/17/2015.
Action must be taken by 8/23/17 in order to be considered for this settlement.

Individuals who believe they may qualify for this settlement need to contact an attorney immediately.

Under terms of the settlement agreement, only individuals who are signed with an attorney by August 23, 2017 and who meet a specified criteria will be included.

You may qualify for inclusion in this settlement if you took Benicar, Benicar HCT, Azor or Tribenzor after May 17, 2015, and you saw a medical professional for gastrointestinal symptoms/side effects such as:

  • Vomiting
  • Chronic diarrhea
  • Rapid and excessive weight loss
  • Dehydration
  • Malnutrition
  • Cardiovascular problems

Benicar lawsuit settlement reached

Benicar is used to treat high blood pressure, is sometimes prescribed in addition to other blood pressure medications.

In July 2013, The FDA warned health professionals and consumers that the blood pressure drug olmesartan medoxomil (which includes Benicar, Benicar HCT, Azor and Tribenzor) could cause intestinal problems known as sprue-like enteropathy.

These warnings come after several Mayo Clinic studies linked Benicar use to symptoms that resembled celiac disease.

According to the FDA, enteropathy develops months to years after starting Benicar and sometimes required hospitalization.

The FDA received thousands of reports of individuals with GI injuries.

The FDA revised the label to include the risk of sprue-like enteropathy and warned consumers that if they experienced any symptoms of sprue-like enteropathy, they should discontinue olmesartan.

In July 2015, hundreds of Benicar lawsuits filed in state and federal courts across the U.S. were consolidated into a multidistrict litigation and centralized in the District of New Jersey under the care of the Honorable Robert B. Kugler.

Movement on those cases is now put on hold as attorneys contact plaintiffs with regards to the settlement offers.

Table of Contents
Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Related Articles

TruLaw FDA Warning Image

FDA warns – Updated warning and recommendations issued for patients and health care providers regarding risk of liver injury when taking Veozah (fezolinetant)

On Thursday, the FDA issued a warning regarding the potential for “serious liver injury” in patients taking the medication Veozah (fezolinetant). Along with the warning, the FDA released updated recommendations regarding precautions health care professionals should take when prescribing Veozah and signs and symptoms patients

Read More »
September 13, 2024

Helpful Sites & Resources